STAAR Surgical Company

NASDAQ:STAA

Medical - Instruments & Supplies

Healthcare
$25.35 -1.37%

-$0.40 today

Market cap
$1.27B
Beta
1.23
P/E (TTM)
-68.3
EPS (TTM)
-$0.42
52W Low $15.59High $35.87

Volume 0.45M

Average 1.07M

STAA Acquisitions (Net)

Cash paid for acquiring businesses, net of cash acquired.

STAAR Surgical CompanyNASDAQ: STAA

Acquisitions (Net) · Q1 FY2026 · quarter ended Apr 2026

Acquisitions (net) outflow grows to $0

Q1 FY2026 acquisitions (net) was $0, compared with $0 a year earlier. Trailing-twelve-month acquisitions (net) was $0.

Context

  • Acquisitions (net) amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Acquisitions (net) increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly acquisitions (net) holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterApr 2026
$0— QoQ
Last fiscal yearJan 2026
$0— YoY
LTMApr 2026
$0— YoY
Acquisitions (Net) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Acquisitions (Net) history

USD · from the cash flow

Latest · FY2025
0 USD
Year-over-year change
—

Acquisitions (Net) vs competitors

How STAA compares with its peers on the latest reported figures

  • STAA's LTM Apr 2026 acquisitions (net) of $0 is the 4th largest of the 5 companies compared; the peer median is $1.8M.
  • Acquisitions (net) amounts to 0.0% of revenue for STAA, versus a peer median of 0.0%.
STAA Competitors Peer median
Acquisitions (Net) for STAA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BLCOBausch + Lomb CorporationLTM Jun 2026$7.99M -94.6%—0.2%
COOThe Cooper Companies, Inc.LTM Jul 2026$3.6M -99.0%-81.2%0.1%
ALCAlcon Inc.LTM Sep 2026$1M +100.1%+1.7%0.0%
STAASTAAR Surgical CompanyLTM Apr 2026$0 ——0.0%
RXSTRxSight, Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding STAA) $1.8M-94.6%-39.8%0.0%

Competitors are the stored peer set for STAA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Jan 2026
Net Income27.51M39.01M21.35M(20.21M)(80.45M)
Depreciation & Amortization3.64M4.51M5.12M6.89M8.32M
Deferred Income Tax(1.52M)(1.34M)3.26M3.59M(2.92M)
Stock-Based Compensation14.61M20.37M23.52M27.21M30.59M
Change in Working Capital(2.39M)(29.13M)(40.84M)(5.4M)(16.33M)
Accounts Receivables(8.87M)(19.6M)(32.76M)16.49K27.83M
Inventory66K(7.94M)(14.36M)(10K)(16.98M)
Accounts Payables108K1.81M(701K)75(5.51M)
Other Working Capital6.3M(3.39M)6.98M(5.41M)(21.67M)
Other Non-Cash Items2.11M2.3M2.18M3.64M26.55M
Operating Cash Flow43.96M35.72M14.59M15.73M(34.23M)
Capital Expenditures(13.65M)(18.11M)(18.19M)(23.39M)(5.82M)
Acquisitions (Net)0138.27M000
Purchases of Investments0(155.75M)(52.31M)(80.24M)(75.36M)
Sales of Investments017.48M144.85M44.42M127.32M
Other Investing Activities0(138.27M)00198K
Investing Cash Flow(13.65M)(156.38M)74.35M(59.22M)46.34M
Debt Repayment(1.65M)(126K)(161K)(165K)(42K)
Common Stock Issued1K1K1K2K3.47M
Common Stock Repurchased00(2.1M)(1.51M)(6.46M)
Dividends Paid00000
Other Financing Activities19.44M8.42M9.67M7.39M(1.52M)
Financing Cash Flow17.79M8.3M7.42M5.72M(4.56M)
Effect of Forex Changes(857K)(862K)202K(1.11M)1.44M
Net Change in Cash47.25M(113.23M)96.56M(38.88M)8.99M
Free Cash Flow30.32M17.61M(3.59M)(7.67M)(40.05M)

STAAR Surgical Company

NASDAQ:STAA

Intrinsic Alpha fair value

Locked

Current Price

$25.35

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.